We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$239M
AUM Growth
-$180M
Cap. Flow
-$206M
Cap. Flow %
-86.24%
Top 10 Hldgs %
40.1%
Holding
108
New
40
Increased
9
Reduced
23
Closed
33

Top Buys

Rank Stock Value
1
ARM icon
Arm
ARM
+$12.2M
2
STX icon
Seagate
STX
+$7.4M
3
ALIT icon
Alight
ALIT
+$6.65M
4
PR
Permian Resources
PR
+$6.3M
5
CART icon
Maplebear
CART
+$6.2M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$165M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$31.4M
3
GPCR icon
Structure Therapeutics
GPCR
+$23.8M
4
RDNT icon
RadNet
RDNT
+$9.79M
5
NXT icon
Nextpower Inc
NXT
+$7.97M

Sector Composition

Rank Sector Weight
1 Healthcare 32.29%
2 Technology 15.94%
3 Energy 11.64%
4 Industrials 7.33%
5 Consumer Discretionary 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
51
Crinetics Pharmaceuticals
CRNX
$8.93B
$814K 0.34%
+27,371
New +$564K
AMAM
52
DELISTED
Ambrx Biopharma Inc
AMAM
$805K 0.34%
+70,000
New +$953K
IMGN
53
DELISTED
Immunogen Inc
IMGN
$635K 0.27%
+40,000
New +$665K
RYZB
54
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$611K 0.26%
+27,500
New +$577K
TRNS icon
55
Transcat
TRNS
$850M
$588K 0.25%
+6,000
New +$573K
ASUR icon
56
Asure Software
ASUR
$243M
$561K 0.23%
+59,301
New +$718K
XFOR icon
57
X4 Pharmaceuticals
XFOR
$425M
$466K 0.19%
14,242
-4,851
-25% -$212K
SLGC
58
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$409K 0.17%
171,193
-628,591
-79% -$1.39M
CDTX
59
DELISTED
Cidara Therapeutics
CDTX
$348K 0.15%
18,455
– –
SEAT icon
60
Vivid Seats
SEAT
$82.7M
$321K 0.13%
2,500
-6,205
-71% -$915K
MOND
61
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$268K 0.11%
75,000
-170,000
-69% -$1.14M
PCT icon
62
PureCycle Technologies
PCT
$1.44B
$65.9K 0.03%
+11,754
New +$110K
SRZNW icon
63
Surrozen Inc Warrant
SRZNW
$8.86K
$3.41K ﹤0.01%
82,986
-37,396
-31% -$1.73K
AXSM icon
64
Axsome Therapeutics
AXSM
$11.4B
– –
-75,000
Closed -$5.39M
BDTX icon
65
Black Diamond Therapeutics
BDTX
$113M
– –
-170,000
Closed -$859K
CAVA icon
66
CAVA Group
CAVA
$7.06B
– –
-5,000
Closed -$205K
COGT icon
67
Cogent Biosciences
COGT
$7.03B
– –
-50,000
Closed -$592K
DAWN
68
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-199,900
Closed -$2.39M
ENLT icon
69
Enlight Renewable Energy
ENLT
$11.4B
– –
-50,263
Closed -$892K
GEHC icon
70
GE HealthCare
GEHC
$33.1B
– –
-90,000
Closed -$7.31M
GH icon
71
Guardant Health
GH
$22.7B
– –
-37,000
Closed -$1.32M
GPOR icon
72
Gulfport Energy Corp
GPOR
$2.97B
– –
-20,000
Closed -$2.1M
GTLS
73
DELISTED
Chart Industries
GTLS
– –
-27,000
Closed -$4.31M
IRON icon
74
Disc Medicine
IRON
$2.99B
– –
-45,000
Closed -$2M
KURA icon
75
Kura Oncology
KURA
$843M
– –
-120,000
Closed -$1.27M
1 2
3
4

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Monashee Investment Management held 108 positions worth $239M, down 43% from $419M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Monashee Investment Management withdrew a net $206M in Q3 2023, closing 33 positions and reducing 23 holdings. Its most notable exit was Vanguard Morningstar Total Stock Market ETF, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 20% a quarter earlier, followed by Technology and Energy.

Against the trend, Monashee Investment Management opened a new position in Arm worth $11.8M.

  • Monashee Investment Management's largest Q3 2023 buy was Arm: 221,325 shares worth $11.8M.
  • Monashee Investment Management added most to Alight in Q3 2023, an estimated $6.65M increase.
  • Monashee Investment Management's biggest Q3 2023 reduction was Structure Therapeutics, cutting an estimated $23.8M.
  • Monashee Investment Management fully exited Vanguard Morningstar Total Stock Market ETF in Q3 2023, selling an estimated $165M.
  • Monashee Investment Management's ten largest holdings make up 40% of its $239M portfolio in Q3 2023.
  • Monashee Investment Management opened 40 new positions and closed 33 in Q3 2023.
  • Monashee Investment Management's portfolio value fell 43% quarter-over-quarter to $239M.

Based on Monashee Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.